Law ❯ Litigation ❯ Securities Litigation ❯ Class Action

Investor Rights

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

The case is in its early phase with no class certified.

Law Firms Urge Vital Farms Investors to Seek Lead Role in ERP-Related Securities Suits

Medpace Investors Invited to Seek Lead Role in Securities Suit by June 8

ImmunityBio Investors Face May 26 Deadline to Seek Lead Role in Securities Case

Eos Energy Investors Face May 5 Deadline in Securities Case Over Factory Setbacks

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

UniQure Investors Face Lead‑Plaintiff Deadline in Securities Fraud Case

Plaintiff Firms Push Investor Alerts on Securities Suits as Filing Deadlines Near

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

Super Micro Faces Shareholder Lawsuits After DOJ Alleges $2.5 Billion China Export Scheme

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

Ardent Health Investors Urged to Seek Lead Role Before March 9 in Securities Class Action

Richtech Robotics Faces Securities Class Action Over Microsoft Tie as Firms Seek Lead Plaintiff

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

Law Firms Press Ardent Health Investors as March 9 Lead-Plaintiff Deadline Nears in Securities Case

Vistagen Investors Urged to Seek Lead Plaintiff Role in Securities Suit as March 16 Deadline Nears

Ramaco Investors Urged to Seek Lead Role by March 31 in Securities Suit Over Brook Mine Claims

BellRing Faces Securities Class Action in SDNY Over Alleged Misstatements on Demand

Coupang Investors Face Feb. 17 Lead‑Plaintiff Deadline in Data‑Breach Securities Fight

Ardent Health Class Action Advances as March 9 Lead‑Plaintiff Deadline Nears